A randomised controlled trial of Prostar Plus for haemostasis in patients after coronary angioplasty

to clarify the efficacy and safety of Prostar Plus, a new percutaneous vascular surgical device (PVS) for vascular haemostasis. prospective randomised controlled trial. a consecutive series of 60 patients were randomised to either PVS (n =30) or conventional manual compression ( n =30) following cor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of vascular and endovascular surgery 2000-05, Vol.19 (5), p.451-455
Hauptverfasser:	Noguchi, T, Miyazaki, S, Yasuda, S, Baba, T, Sumida, H, Morii, I, Daikoku, S, Goto, Y, Nonogi, H
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty, Balloon, Coronary - adverse effects Coronary Disease - therapy Equipment Design Equipment Safety Female Femoral Artery Hemostasis, Surgical - instrumentation Hemostasis, Surgical - methods Hospital Costs Humans Length of Stay Male Middle Aged Postoperative Hemorrhage - etiology Postoperative Hemorrhage - prevention & control Prospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	to clarify the efficacy and safety of Prostar Plus, a new percutaneous vascular surgical device (PVS) for vascular haemostasis. prospective randomised controlled trial. a consecutive series of 60 patients were randomised to either PVS (n =30) or conventional manual compression ( n =30) following coronary angioplasty or stenting with femoral access using an 8-F sheath. PVS significantly shortened the time to haemostasis (10 s.d. 3 vs. 27 s.d. 9 min, p
ISSN:	1078-5884
DOI:	10.1053/ejvs.1999.1071